20 May 2013
Keywords: roche, oral, anti-cmv, prodrug, approved, been, granted
Article | 05 April 2001
Roche has been granted approval by the US Food and Drug Administrationfor its oral prescription drug Valcyte (valganciclovir), to treat
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 April 2001
17 May 2013
© 2013 thepharmaletter.com